Abhijith Mally, MD
Urology · Snellville, GANPI 1609030014
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,854 of the $21,771 with a category attached, or 63.6%. Medtronic accounts for 66.0% of it on its own, with 36 other manufacturers making up the rest. 2025 is the largest year on record at $7,622, 5.9 times the $1,287 reported in 2019. Among urology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $74.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$14K
- Baxter Healthcare$1K
- Teleflex LLC$926
- Astellas Pharma US Inc$643
- Dendreon Pharmaceuticals LLC$470
- Endo Pharmaceuticals Inc.$465
- plus $4K from 31 others
What the payments were for
- Speaking & faculty fees$7,50034%
- Food & beverage$13,85464%
- Education$4172%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 97 | $14,369 |
| Baxter Healthcare | 8 | $1,066 |
| Teleflex LLC | 13 | $926 |
| Astellas Pharma US Inc | 25 | $643 |
| Dendreon Pharmaceuticals LLC | 6 | $470 |
| Endo Pharmaceuticals Inc. | 4 | $465 |
| Johnson & Johnson(2 entities) | 12 | $372 |
| Sumitomo Pharma America, Inc. | 17 | $333 |
| Coloplast | 6 | $275 |
| Ambu Inc. | 5 | $249 |
| Boston Scientific | 3 | $239 |
| AbbVie(2 entities) | 10 | $231 |
| AstraZeneca | 10 | $208 |
| Pfizer | 12 | $206 |
| Myovant Sciences Inc. | 5 | $186 |
| Merck | 8 | $184 |
| Integra Lifesciences Corporation | 1 | $157 |
| Neotract Inc. | 2 | $151 |
| Myriad Genetic Laboratories, Inc. | 3 | $142 |
| Blue Earth Diagnostics | 6 | $122 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $100 |
| Rochester Medical Corporation | 4 | $84 |
| Tempus AI, Inc | 3 | $79 |
| Urogen Pharma, Inc. | 3 | $65 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $62 |
| Accord Healthcare, Inc. | 3 | $55 |
| Novartis | 2 | $47 |
| Verity Pharmaceuticals Inc. | 2 | $44 |
| Bayer | 2 | $42 |
| Olympus America Inc. | 2 | $32 |
| Travere Therapeutics, Inc. | 8 | $31 |
| Antares Pharma, Inc. | 1 | $30 |
| Urovant Sciences Inc | 2 | $29 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Calyxo, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$12,301
- TISSEEL$568
- UroLift$536
- PROVENGE$397
- XIAFLEX$377
- FLOSEAL$269
- UroLift System$231
- INTERSTIM ICON$179
- TITAN$159
- TENOGLIDE$157
- PerClot$149
- AMS$116
- Prolaris$110
- SpaceOAR VUE System - 10mL$108
- ORGOVYX$107
How this compares
$21,771 in reported general payments places this provider in the 90th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 70 | $1,036,036 |
| OrgovyxRelugolix | 142 | $386,362 |
| NubeqaDarolutamide | 22 | $291,588 |
| XtandiEnzalutamide | 18 | $261,855 |
| MyrbetriqMirabegron | 279 | $196,448 |
| GemtesaVibegron | 210 | $156,450 |
| Abiraterone Acetate | 19 | $20,994 |
| Estradiol | 117 | $7,712 |
| Tamsulosin Hcl | 700 | $6,994 |
| Methenamine Hippurate | 59 | $5,280 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 26 | $4,295 |
| Potassium Citrate ErPotassium Citrate | 27 | $2,596 |
| Finasteride | 149 | $1,676 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 87 | $1,596 |
| Testosterone Cypionate | 27 | $1,544 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $372 | $1,036,03670 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $333 | $542,812352 claims |
| Astellas Pharma US IncXtandi, Myrbetriq | $643 | $458,303297 claims |
| BayerNubeqa | $42 | $291,58822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 369 urology providers in Georgia.
Other urology in Snellville
- Ronald AngladeSnellville$31K
- Vikram SabarwalSnellville$13K
- Vahan KassabianRoswell$1.6M
- Lewis KritemanRoswell$864K
- Daniel CanterDecatur$329K
- Tariq HakkyAtlanta$140K
- Sherita KingAugusta$108K
- Brittani Barrett-HarlowFayetteville$100K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.